 Goldman Sachs Group Inc. lifted its position in Principia Biopharma Inc NASDAQ:PRNB by 106.2 in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 61,014 shares of the companys stock after purchasing an additional 31,429 shares during the quarter. Goldman Sachs Group Inc. ... 